Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$60.76
$69.58
$58.75
$89.77
$27.64B0.746.39 million shs4.78 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$88.15
0.0%
$86.23
$62.00
$123.78
$2.99B0.67675,209 shs390,437 shs
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$93.91
$81.92
$47.25
$98.27
$6.11B-0.08929,978 shs926,921 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$322.24
0.0%
$330.98
$221.26
$362.41
$12.67B0.74514,728 shs443,675 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%-4.27%-18.62%-24.37%-16.92%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%0.00%-2.46%+2.60%-27.18%
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
0.00%+0.91%+12.04%+35.36%+15.60%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%+0.03%-3.06%-5.10%+14.64%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$60.76
$69.58
$58.75
$89.77
$27.64B0.746.39 million shs4.78 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$88.15
0.0%
$86.23
$62.00
$123.78
$2.99B0.67675,209 shs390,437 shs
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$93.91
$81.92
$47.25
$98.27
$6.11B-0.08929,978 shs926,921 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$322.24
0.0%
$330.98
$221.26
$362.41
$12.67B0.74514,728 shs443,675 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.00%-4.27%-18.62%-24.37%-16.92%
Integer Holdings Corporation stock logo
ITGR
Integer
0.00%0.00%-2.46%+2.60%-27.18%
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
0.00%+0.91%+12.04%+35.36%+15.60%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%+0.03%-3.06%-5.10%+14.64%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.41
Hold$80.6732.76% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
2.27
Hold$98.2911.50% Upside
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
2.73
Moderate Buy$99.716.18% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.18
Hold$361.3312.13% Upside

Current Analyst Ratings Breakdown

Latest PEN, LNTH, ITGR, and GEHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/15/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
DowngradeHold (C)Hold (C-)
5/11/2026
Integer Holdings Corporation stock logo
ITGR
Integer
DowngradeHoldStrong Sell
5/11/2026
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
Reiterated RatingBuy$98.00 ➝ $115.00
5/8/2026
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
Reiterated RatingOutperform
5/8/2026
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
Boost Price TargetMarket Outperform$85.00 ➝ $115.00
5/8/2026
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
Boost Price TargetOutperform$95.00 ➝ $100.00
5/7/2026
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
Reiterated RatingNeutral$94.00
5/7/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Reiterated RatingOutperform$335.00
5/7/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Lower Price TargetNeutral$374.00 ➝ $350.00
5/1/2026
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
Reiterated RatingBuy
5/1/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Lower Price Target$95.00 ➝ $88.00
(Data available from 5/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$20.63B1.34$5.88 per share10.34$22.80 per share2.66
Integer Holdings Corporation stock logo
ITGR
Integer
$1.85B1.61$10.37 per share8.50$49.85 per share1.77
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$1.54B3.97$6.38 per share14.71$16.43 per share5.72
Penumbra, Inc. stock logo
PEN
Penumbra
$1.40B9.03$4.30 per share74.98$36.45 per share8.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$2.08B$4.1814.5411.251.379.10%20.46%5.73%7/29/2026 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$4.0121.9813.002.087.64%12.83%6.51%7/23/2026 (Estimated)
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$233.56M$4.1522.6317.42N/A18.05%29.32%15.00%8/5/2026 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$177.69M$4.3474.2550.121.9711.76%10.87%8.45%8/4/2026 (Estimated)

Latest PEN, LNTH, ITGR, and GEHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$1.25$1.46+$0.21$1.80$354.48 million$377.33 million
5/6/2026Q1 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.06$0.82-$0.24$0.82$370.47 million$374.76 million
4/30/2026Q1 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.21$1.20-$0.01$0.48$426.48 million$439.58 million
4/29/2026Q1 2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.07$0.99-$0.08$0.85$5.04 billion$5.13 billion
2/26/2026Q4 2025
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
$1.17$1.67+$0.50$0.82$367.03 million$406.79 million
2/25/2026Q4 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$1.12-$0.37-$1.49-$0.52$367.18 million$385.39 million
2/19/2026Q4 2025
Integer Holdings Corporation stock logo
ITGR
Integer
$1.70$1.76+$0.06$1.38$462.73 million$472.06 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.23%N/A3.35%1 Years
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.95
1.22
0.95
Integer Holdings Corporation stock logo
ITGR
Integer
0.77
3.75
2.38
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
0.47
2.83
2.64
Penumbra, Inc. stock logo
PEN
Penumbra
0.01
6.02
3.95

Institutional Ownership

CompanyInstitutional Ownership
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
99.06%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%

Insider Ownership

CompanyInsider Ownership
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.36%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
1.70%
Penumbra, Inc. stock logo
PEN
Penumbra
2.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
54,000454.89 million453.25 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00033.96 million33.58 millionOptionable
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
1,19365.11 million64.00 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,70039.33 million38.19 millionOptionable

Recent News About These Companies

Citigroup Cuts Penumbra (NYSE:PEN) Price Target to $350.00
Penumbra: Q1 Earnings Snapshot

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$60.76 0.00 (0.00%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$60.62 -0.14 (-0.23%)
As of 06:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Integer stock logo

Integer NYSE:ITGR

$88.15 -0.01 (-0.01%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$89.22 +1.07 (+1.22%)
As of 06:53 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Lantheus stock logo

Lantheus NASDAQ:LNTH

$93.91 0.00 (0.00%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$94.10 +0.20 (+0.21%)
As of 06:16 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent to assess blood flow to the muscle of the heart; and PYLARIFY, an F 18-labelled PSMA-targeted PET imaging agent used for imaging of PSMA positive-lesions in men with prostate cancer. The company also offers Automated Bone Scan Index that calculates the disease burden of prostate cancer by detecting and classifying bone scan tracer uptakes as metastatic or benign lesions using an artificial neural network; RELISTOR for opioid-induced constipation; and aPROMISE, an artificial intelligence medical device software; and PYLARIFY AI, an AI-based medical device software to perform quantitative assessment of PSMA PET/CT images in prostate cancer. In addition, it develops 1095, a PSMA-targeted iodine-131-labeled small molecule; PNT2002, a radiopharmaceutical therapy to treat mCRPC; PNT2003, an SSTR therapy that treats patients with SSTR-positive neuroendocrine tumors; MK-6240, a F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer's disease; LNTH-1363S, an fibroblast activation protein, alpha targeted, copper-64 labeled PET imaging agent; and flurpiridaz used to assess blood flow to the heart;. It has collaboration agreements with GE Healthcare; NanoMab Technology Limited; Curium; RefleXion Medical, Inc.; POINT; Regeneron Pharmaceuticals, Inc; and Ratio Therapeutics LLC. The company was founded in 1956 and is based in Bedford, Massachusetts.

Penumbra stock logo

Penumbra NYSE:PEN

$322.24 -0.08 (-0.02%)
Closing price 05/15/2026 03:59 PM Eastern
Extended Trading
$322.32 +0.08 (+0.02%)
As of 04:12 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.